| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C0010362> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C0019993> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C0033106> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C0036744> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C0041703> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C0600367> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C1135927> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C1564867> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C3494318> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5244032> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5244064> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5392165> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5392218> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5392882> <https://research.tib.eu/covid-19/entity/33399860_HAS_TOPIC_C5392980>
?:authorAffiliation	[\'Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, Pennsylvania.\', \'Center for Observational and Real-World Evidence, Merck & Co Inc, Kenilworth, New Jersey.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Angulo_Frederick_J> <https://research.tib.eu/covid-19/entity/Finelli_Lyn> <https://research.tib.eu/covid-19/entity/Swerdlow_David_L>
?:doi	10.1001/jamanetworkopen.2020.33706
?:doi	<https://research.tib.eu/covid-19/entity/10.1001/jamanetworkopen.2020.33706>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	JAMA network open
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33399860> <https://research.tib.eu/covid-19/entity/nimwyae5>
?:pmid	<https://research.tib.eu/covid-19/entity/33399860>
?:pmid	33399860
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33399860>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33399860>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all